Literature DB >> 22902678

Economic impact of the 2009-2010 Guam mumps outbreak on the public health sector and affected families.

Abdirahman Mahamud1, A Parker Fiebelkorn, George Nelson, Annette Aguon, John McKenna, Gissela Villarruel, Kathleen Gallagher, Ismael R Ortega-Sánchez.   

Abstract

BACKGROUND: The United States Territory of Guam reported a large mumps outbreak of 505 cases during 2009-2010. We assessed the economic impact of the outbreak from the perspectives of the local public health sector and affected families.
METHODS: Using standard cost analysis methods, we retrospectively identified all public health personnel involved in the outbreak response and surveyed them about their outbreak-related activities. We then estimated the costs of outbreak-related personnel hours and materials. We also assessed out-of-pocket costs and costs incurred for work-time missed for persons with mumps and their families. We defined the analysis period as February 25-October 22, 2010.
RESULTS: Seventy-six public health personnel were involved in outbreak response activities. Overall, the response required approximately 8264 person-hours, 2380 miles driven, and 3000 doses of measles-mumps-rubella vaccine ordered. The cost to the public health sector was 256,785 U.S. dollars (USD). Families of 102 persons with mumps were interviewed. An estimated 761 USD per person with mumps was spent by families; 88% of this cost was due to missed days of work. The estimated total cost to families of the 470 persons with mumps during the analysis period was 357,670 USD. Total outbreak-related costs were 614,455 USD.
CONCLUSIONS: The costs reported underscore the impact of mumps outbreaks in highly vaccinated populations and the need for effective mumps prevention and control strategies. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22902678     DOI: 10.1016/j.vaccine.2012.08.001

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Immunogenicity of novel mumps vaccine candidates generated by genetic modification.

Authors:  Pei Xu; Zhenhai Chen; Shannon Phan; Adrian Pickar; Biao He
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

2.  Epidemiology and the economic assessment of a mumps outbreak in a highly vaccinated population, Orange County, New York, 2009-2010.

Authors:  Preeta Krishnan Kutty; Jacqueline Lawler; Elizabeth Rausch-Phung; Ismael R Ortega-Sanchez; Stephen Goodell; Cynthia Schulte; Lynn Pollock; Barbara Valure; Jean Hudson; Kathleen Gallagher; Debra Blog
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

Review 3.  Development of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genes.

Authors:  Christopher C Stobart; Martin L Moore
Journal:  Expert Rev Vaccines       Date:  2015-10-05       Impact factor: 5.217

4.  Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control.

Authors:  Cristina V Cardemil; Rebecca M Dahl; Lisa James; Kathleen Wannemuehler; Howard E Gary; Minesh Shah; Mona Marin; Jacob Riley; Daniel R Feikin; Manisha Patel; Patricia Quinlisk
Journal:  N Engl J Med       Date:  2017-09-07       Impact factor: 91.245

5.  Review of the economic evidence presented to the United States Advisory Committee on Immunization Practices, 2012-2016.

Authors:  Jamison Pike; Andrew J Leidner; Jessica R MacNeil; Amanda C Cohn
Journal:  Vaccine       Date:  2018-11-23       Impact factor: 3.641

6.  Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control--Guam 2009 to 2010.

Authors:  George E Nelson; Annette Aguon; Engracia Valencia; Rita Oliva; Michele Leon Guerrero; Richard Reyes; Anna Lizama; Daryl Diras; Annakutty Mathew; E Jessica Camacho; Moryne-Nicole Monforte; Tai-Ho Chen; Abdirahman Mahamud; Preeta K Kutty; Carole Hickman; William J Bellini; Jane F Seward; Kathleen Gallagher; Amy Parker Fiebelkorn
Journal:  Pediatr Infect Dis J       Date:  2013-04       Impact factor: 2.129

7.  2016-2017 Arkansas mumps outbreak in a close-knit community: Assessment of the economic impact and response strategies.

Authors:  Jamison Pike; Mona Marin; Angela Guo; Dirk Haselow; Haytham Safi; Fangjun Zhou
Journal:  Vaccine       Date:  2019-12-06       Impact factor: 3.641

8.  Cost of Public Health Response and Outbreak Control With a Third Dose of Measles-Mumps-Rubella Vaccine During a University Mumps Outbreak-Iowa, 2015-2016.

Authors:  Mona Marin; Tricia L Kitzmann; Lisa James; Patricia Quinlisk; Wade K Aldous; John Zhang; Cristina V Cardemil; Chris Galeazzi; Manisha Patel; Ismael R Ortega-Sanchez
Journal:  Open Forum Infect Dis       Date:  2018-10-04       Impact factor: 3.835

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.